Caritas Healthcare Private Limited — Tacrolimus Exporter Profile
Indian Pharmaceutical Exporter · #10 for Tacrolimus · $1.7M export value · DGFT Verified
Caritas Healthcare Private Limited is the #10 Indian exporter of Tacrolimus with $1.7M in export value and 34 verified shipments. Caritas Healthcare Private Limited holds a 0.8% market share in Tacrolimus exports across 2 countries. The company exports 9 pharmaceutical products worth $7.2M across 6 therapeutic categories.
Caritas Healthcare Private Limited — Tacrolimus Export Profile: Buyers & Destinations
Where Does Caritas Healthcare Private Limited Export Tacrolimus?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $1.1M | 23 | 81.7% |
| ECUADOR | $238.5K | 11 | 18.3% |
Caritas Healthcare Private Limited exports Tacrolimus to 2 countries. The largest destination is MEXICO accounting for 81.7% of Caritas Healthcare Private Limited's Tacrolimus shipments. These destinations reflect Caritas Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tacrolimus from Caritas Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CARITAS PHARMA, S.A. DE C.V | MEXICO | $385.2K | 8 |
| CARITAS PHARMA, S.A. DE C.V. | MEXICO | $278.7K | 7 |
| F.D.E.C.A | ECUADOR | $238.5K | 11 |
| CARITAS PHARMA S A DE C V | MEXICO | $200.0K | 4 |
| CARITAS PHARMA SA DE | MEXICO | $100.0K | 2 |
| CARITAS PHARMA S.A DE C.V. | MEXICO | $100.0K | 2 |
Caritas Healthcare Private Limited supplies Tacrolimus to 6 buyers globally. The largest buyer is CARITAS PHARMA, S.A. DE C.V (MEXICO), followed by CARITAS PHARMA, S.A. DE C.V. (MEXICO) and F.D.E.C.A (ECUADOR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tacrolimus Export Value and How Much Does Caritas Healthcare Private Limited Contribute?
India exported $92.4M worth of Tacrolimus through 4,611 shipments from 299 suppliers to 127 countries, serving 727 buyers globally. Caritas Healthcare Private Limited contributes $1.7M to this total, accounting for 0.8% of India's Tacrolimus exports. Caritas Healthcare Private Limited ships Tacrolimus to 2 countries through 6 buyers.
What Is the Average Shipment Value for Caritas Healthcare Private Limited's Tacrolimus Exports?
Caritas Healthcare Private Limited's average Tacrolimus shipment value is $50.0K per consignment, based on 34 shipments totaling $1.7M. The largest destination is MEXICO (81.7% of Caritas Healthcare Private Limited's Tacrolimus exports).
How Does Caritas Healthcare Private Limited Compare to Other Indian Tacrolimus Exporters?
Caritas Healthcare Private Limited ranks #10 among 299 Indian Tacrolimus exporters with a 0.8% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($36.9M), INTAS PHARMACEUTICALS LIMITED ($22.5M), ALKEM LABORATORIES LIMITED ($8.4M). Caritas Healthcare Private Limited processed 34 shipments to 2 destination countries.
What Tacrolimus Formulations Does Caritas Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FINISHED PHARAMCEUTICAL PRODUCT - TACROLIMUS CAPSUAL 1MG - TACROCORD 1MG B.NO.TVEX25011B | $150.0K | 3 |
| TACROLIMUS APSUAL 1 MG -PLASCORD 1 MG | $78.7K | 3 |
| PLASCORD TACROLIMUS 1 MG B NO TVMX23002A | $50.0K | 1 |
| TACROLIMUS CAPSUAL 1 MG-PLASCORD 1MG B.NO.TVMX23004A | $50.0K | 1 |
| TACROLIMUS CAPSUAL 1 MG-PLASCORD 1MG | $50.0K | 1 |
| TACROLIMUS CAPSUAL 5 MG-PLASCORD 5MG B.NO.TZMX23003B | $50.0K | 1 |
| FINISHED PHARMA PRODUCT: TACROLIMUS CAPSUAL 1MG-PLASCORD 1MG BNO. TVEX24023A MFGDT: NOV-24 EXPDT: OCT-26(12528X5X10 CAP) | $50.0K | 1 |
| FINISHED PHARMA PRODUCT: TACROLIMUS CAPSUAL 1MG-PLASCORD 1MG BNO. TVEX24023B MFGDT: NOV-24 EXPDT: OCT-26(6264X10X10 CAP) | $50.0K | 1 |
| FINISHED PHARMACEUTICAL PRODUCT - TACROLIMUS CAPSUAL 5MG - PLASCORD 5MG B.NO.TZEX24002A,TZEX24003A,TZEX24004A | $50.0K | 1 |
| FINISHED PHARMACEUTICAL PRODUCT - TACROLIMUS CAPSUAL 1MG -PLASCORD 1MG BATCH NO.TVEX25004A | $50.0K | 1 |
Caritas Healthcare Private Limited exports 29 distinct Tacrolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FINISHED PHARAMCEUTICAL PRODUCT - TACROLIMUS CAPSUAL 1MG - T with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Tacrolimus to Key Markets
What Caritas Healthcare Private Limited must comply with to export Tacrolimus to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Caritas Healthcare Private Limited Compare to Nearest Tacrolimus Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | GLENMARK PHARMACEUTICALS LIMITED | $2.1M | 58 | 13 | $36.2K |
| 13 | ENCUBE ETHICALS PRIVATE LIMITED | $2.0M | 44 | 1 | $45.1K |
| 10 | CARITAS HEALTHCARE PRIVATE LIMITED ★ | $1.7M | 34 | 2 | $50.0K |
| 9 | DR REDDYS LABORATORIES LIMITED | $1.4M | 27 | 2 | $50.0K |
| 15 | DR.REDDY'S LABORATORIES LIMITED | $1.1M | 34 | 2 | $33.0K |
Caritas Healthcare Private Limited ranks #10 among 299 Indian Tacrolimus exporters. Average shipment value of $50.0K compared to the market average of $309.1K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and ENCUBE ETHICALS PRIVATE LIMITED.
Which Indian Ports Ship Tacrolimus Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 741 | 16.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 645 | 14.0% |
| DELHI AIR CARGO ACC (INDEL4) | 398 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 358 | 7.8% |
| DELHI AIR | 320 | 6.9% |
| AHEMDABAD AIR ACC (INAMD4) | 175 | 3.8% |
| JNPT/ NHAVA SHEVA SEA | 169 | 3.7% |
| Bombay Air | 141 | 3.1% |
Geopolitical & Trade Policy Impact on Caritas Healthcare Private Limited's Tacrolimus Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Caritas Healthcare. The Israel-Iran conflict has disrupted Middle East trade routes, leading to increased shipping costs and logistical complexities. Reports indicate that maritime carriers have suspended bookings for sailings into the Persian Gulf, and vessels are being diverted around the Cape of Good Hope, extending transit times and escalating freight charges. (pharmaceuticalcommerce.com) These disruptions necessitate strategic adjustments in shipment schedules and inventory management to mitigate potential losses.
Conversely, the India–European Union Free Trade Agreement, concluded on January 27, 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. (en.wikipedia.org) This development offers Caritas Healthcare an opportunity to strengthen its presence in the European market, capitalizing on reduced trade barriers and increased competitiveness.
Caritas Healthcare Private Limited — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the United States in the number of FDA-registered generic manufacturing sites as of 2024. (business-standard.com) This achievement reflects a concerted effort to adhere to stringent international quality standards. For Caritas Healthcare, maintaining compliance with FDA, WHO GMP, and EU regulations is imperative to sustain and expand its export operations. Continuous investment in quality assurance and regulatory adherence will be crucial in navigating the evolving global pharmaceutical landscape.
About Caritas Healthcare Private Limited
Caritas Healthcare Private Limited exports 9 products worth $7.2M. Beyond Tacrolimus, top products include Carvedilol, Methylprednisolone, Rivaroxaban, Amphotericin, Chloroquine. View the complete Caritas Healthcare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tacrolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Caritas Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 34 individual customs records matching Caritas Healthcare Private Limited exporting Tacrolimus, covering 29 formulations to 2 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 127+ countries, 727+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tacrolimus Export Data from Caritas Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Caritas Healthcare Private Limited's Tacrolimus exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Caritas Healthcare Private Limited
Full Company Profile →
9 products · $7.2M total trade · 6 categories
Tacrolimus Stats
Company Overview
Top Products by Caritas Healthcare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Caritas Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tacrolimus. For current shipment-level data, contact TransData Nexus.